Clinical data shows that approximately 1520% of semaglutide users experience some form of injection site reaction, though severe cases requiring treatment discontinuation remain rare
Their glucose-lowering effect is generally more modest, and most members of this class are considered weight neutral
Track your injection schedule
However, the employer has significant financial risk
Based on clonidine and/or arginine growth hormone stimulation tests, 12 patients were diagnosed with GHD (peak GH below 7.5 ng/ml) and 8 with idiopathic short stature (peak GH above 7.5 ng/ml)
Third, individual-level patient data (IPD) were not available, limiting our ability to adjust for important confounders such as smoking, alcohol intake, family history, and genetic risk